This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medtronic's Acquisition Isn't Just About Lowering Its Tax Bill

Stocks in this article: MDT COV TYC PFE OMC JNJ

NEW YORK (TheStreet) -- Medtronic (MDT), the world's second-biggest maker of medical devices, is making the largest acquisition in its history.

Medtronic is buying Irish competitor Covidien (COV) in a cash and stock deal for $42.9 billion. Medtronic is paying a 29% premium over Covidien's closing price on Friday.

Covidien's shares jumped over 19% on Monday to $86. On the other hand, Medtronic's shares have fallen by 2.9% to around $59.

More on Medtronic and Covidien:

Medtronic to Pay $43B for Ireland's Covidien

Medtronic and Covidien Deal Is Tax Strategy Guiding Healthcare M&A

Will Medtronic's Deal for Covidien Push Stryker to Smith & Nephew?

The deal is good news for Medtronic's shareholders because it allows the company to bring back billions in cash held in overseas markets while avoiding the U.S. corporate tax rate. But while Medtronic is paying a premium, analysts have pointed out that this is not an expensive purchase given the ongoing consolidation in the medical-products industry.

Medtronic is nearly twice as large as Covidien in market cap. Medtronic is known for its cardiovascular and orthopedic devices; Covidien makes feeding pumps, staplers and other surgical devices. Covidien was originally based in Bermuda but relocated to Ireland about five years ago after it spun out from its parent Tyco International (TYC).

The Irish corporate tax rate is 12.5%, one of the lowest in the developed world as opposed to U.S., where tax rate stands at 35%.

These kinds of deals are usually undertaken by companies that have significant cash reserves in the international markets. Bringing the cash home can result in a large tax bill. Some companies, such as Pfizer Inc (PFE) and Omnicom (OMC), have tried to relocate to other countries with substantially lower corporate tax rates by acquiring companies located in tax havens.

Medtronic has $14 billion cash, of which $13.5 billion is held in overseas markets. The deal will allow the company to fulfill its promise to distribute 50% of its free cash flows to shareholders while sidestepping the high taxes in the U.S. 

Medtronic has been using debt to reward its shareholders through dividends and buybacks.Consequently, the company will be able to reduce its reliance on debt. This will be a positive step as the company's debt-to-equity ratio has climbed to 61.35, which is more than three times as large as the industry's average.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs